BioXcel Therapeutics (BTAI) Q1 2025 Earnings

27MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-8.09
-5.46
-2.84
-0.21

Details

Expected EPS
-6.044068
Actual EPS
-3.57
Surprise EPS
2.47
Surprise Percent
+40.93%

Description

BioXcel Therapeutics (BTAI) has reported earnings of -3.57 per share for Q1 2025.

0 Comments

Share your thoughts